rebel Financial rebel Financial
← All Posts
LCTX

Lineage Cell Therapeutics, Inc.

June 11, 2026 • Author: Phil Ratcliff • LCTX
Item Proposal Vote
1 To elect seven directors to hold office until the 2027 annual meeting of shareholders and until their respective successors are duly elected and qualified.
1.01 Michael H. Mulroy ✓ For
1.02 Dipti Amin ✓ For
1.03 Deborah Andrews ✓ For
1.04 Neal C. Bradsher ✓ For
1.05 Brian M. Culley ✗ Against
1.06 Anula Jayasuriya ✓ For
1.07 Angus C. Russell ✓ For
2 To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. ✓ For
3 To approve, on an advisory basis, the compensation paid to our named executive officers. ✓ For
Attachments
📄
LCTX_2025_Annual_Report.pdf 5.3 MB
📄
LCTX_2026_Proxy_Statement.pdf 1.0 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.